As of 2025-05-16, the Fair Value of Milestone Pharmaceuticals Inc (MIST) is -3.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.22 USD, the upside of Milestone Pharmaceuticals Inc is -418.95%.
With the market price of 1.22 USD and our fair value calculation, Milestone Pharmaceuticals Inc (MIST) is not a good investment. Investing in MIST stocks now will result in a potential loss of 418.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -49.97 | -42.85 | -58.39 | -59.69 | -41.52 | -50.48 |
| YoY growth | 9.52% | 14.25% | -36.27% | -2.22% | 30.44% | 3.14% |
| Market Cap (mil) | 65.09 |
| P/E | |
| Forward P/E |
| EPS | -0.78 |
| Avg earnings growth rate | 3.14% |
| TTM earnings | -41.52 |